97 related articles for article (PubMed ID: 24150841)
1. Soluble CD23 measurement by CBA: a convenient and reliable quantification method in chronic lymphocytic leukemia.
Grelier A; Le Garff-Tavernier M; Nauwelaers F; Sarfati M; Merle-Beral H
Cytometry B Clin Cytom; 2014 Mar; 86(2):91-7. PubMed ID: 24150841
[TBL] [Abstract][Full Text] [Related]
2. Soluble CD23 measurement by CBA: A convenient and reliable quantification method in Chronic Lymphocytic Leukemia.
Grelier A; Garff-Tavernier ML; Nauwelaers F; Sarfati M; Merle-Beral H
Cytometry B Clin Cytom; 2013 Oct; ():. PubMed ID: 24123755
[TBL] [Abstract][Full Text] [Related]
3. Prognostic importance of soluble CD23 in B-cell chronic lymphocytic leukemia.
Saka B; Aktan M; Sami U; Oner D; Sanem O; Dinçol G
Clin Lab Haematol; 2006 Feb; 28(1):30-5. PubMed ID: 16430457
[TBL] [Abstract][Full Text] [Related]
4. Cellular expression and serum circulating levels of CD23 in B-cell chronic lymphocytic leukemia. Implications for prognosis.
Molica S; Levato D; Dell'Olio M; Matera R; Minervini M; Dattilo A; Carotenuto M; Musto P
Haematologica; 1996; 81(5):428-33. PubMed ID: 8952156
[TBL] [Abstract][Full Text] [Related]
5. Soluble CD23 and other receptors (CD4, CD8, CD25, CD71) in serum of patients with chronic lymphocytic leukemia.
Beguin Y; Lampertz S; De Groote D; Igot D; Malaise M; Fillet G
Leukemia; 1993 Dec; 7(12):2019-25. PubMed ID: 8255102
[TBL] [Abstract][Full Text] [Related]
6. Soluble CD23 reliably reflects disease activity in B-cell chronic lymphocytic leukemia.
Reinisch W; Willheim M; Hilgarth M; Gasché C; Mader R; Szepfalusi S; Steger G; Berger R; Lechner K; Boltz-Nitulescu G
J Clin Oncol; 1994 Oct; 12(10):2146-52. PubMed ID: 7931486
[TBL] [Abstract][Full Text] [Related]
7. Doubling time of soluble CD23: a powerful prognostic factor for newly diagnosed and untreated stage A chronic lymphocytic leukemia patients.
Meuleman N; Stamatopoulos B; Dejeneffe M; El Housni H; Lagneaux L; Bron D
Leukemia; 2008 Oct; 22(10):1882-90. PubMed ID: 18633433
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of sIL2R, sCD23, sICAM-1, IL6 and sCD 14 serum levels in B-cell chronic lymphocytic leukemia.
Callea V; Morabito F; Luise F; Piromalli A; Filangeri M; Stelitano C; Iacopino P; Nobile F; Brugiatelli M
Haematologica; 1996; 81(4):310-5. PubMed ID: 8870374
[TBL] [Abstract][Full Text] [Related]
9. Prognostic importance of serum soluble CD23 level in chronic lymphocytic leukemia.
Sarfati M; Chevret S; Chastang C; Biron G; Stryckmans P; Delespesse G; Binet JL; Merle-Beral H; Bron D
Blood; 1996 Dec; 88(11):4259-64. PubMed ID: 8943862
[TBL] [Abstract][Full Text] [Related]
10. [Serum levels of soluble CD(23) and thrombopoietin in chronic lymphocytic leukemia].
Yu H; Xu W; Shen QD
Zhonghua Nei Ke Za Zhi; 2008 Oct; 47(10):826-9. PubMed ID: 19080142
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic analysis of receptor-ligand pairs on B-cells in B-chronic lymphocytic leukemia.
Gagro A; Dasić G; Sabioncello A; Rabatić S; Reckzeh B; Havemann K; Kardum I; Jacksić B; Vitale B
Leuk Lymphoma; 1997 Apr; 25(3-4):301-11. PubMed ID: 9168440
[TBL] [Abstract][Full Text] [Related]
12. Effects of alpha-interferon and steroids on CD23 expression and release in B-cell chronic lymphocytic leukemia.
Pozzato G; de Paoli P; Franzin F; Tulissi P; Moretti M; Basaglia G; Santini GF
Haematologica; 1994; 79(3):205-12. PubMed ID: 7926968
[TBL] [Abstract][Full Text] [Related]
13. Quantitative flow cytometry of ZAP-70 levels in chronic lymphocytic leukemia using molecules of equivalent soluble fluorochrome.
Kay S; Herishanu Y; Pick M; Rogowski O; Baron S; Naparstek E; Polliack A; Deutsch VR
Cytometry B Clin Cytom; 2006 Jul; 70(4):218-26. PubMed ID: 16456869
[TBL] [Abstract][Full Text] [Related]
14. Value of CD23 determination by flow cytometry in differentiating mantle cell lymphoma from chronic lymphocytic leukemia/small lymphocytic lymphoma.
Gong JZ; Lagoo AS; Peters D; Horvatinovich J; Benz P; Buckley PJ
Am J Clin Pathol; 2001 Dec; 116(6):893-7. PubMed ID: 11764079
[TBL] [Abstract][Full Text] [Related]
15. [Evolution of chronic lymphocytic leukemia: predictive value of immunophenotype, soluble CD23 and morphology].
Sarmientó MA; Palacios MF; Scolnik MP; Ramírez FR; Stanganelli C; Cabrera J; Chena CP; Arrossagaray G; Slavutsky IR; Bengió RM
Medicina (B Aires); 2002; 62(4):305-12. PubMed ID: 12325485
[TBL] [Abstract][Full Text] [Related]
16. Clinico-prognostic implications of simultaneous increased serum levels of soluble CD23 and beta2-microglobulin in B-cell chronic lymphocytic leukemia.
Molica S; Levato D; Cascavilla N; Levato L; Musto P
Eur J Haematol; 1999 Feb; 62(2):117-22. PubMed ID: 10052715
[TBL] [Abstract][Full Text] [Related]
17. Lag times between lymphoproliferative disorder and clinical diagnosis of chronic lymphocytic leukemia: a prospective analysis using plasma soluble CD23.
Kaaks R; Sookthai D; Łuczyńska A; Oakes CC; Becker S; Johnson T; Johansson A; Melin B; Sjöberg K; Trichopoulos D; Trichopoulou A; Lagiou P; Mattiello A; Tumino R; Masala G; Agnoli C; Boeing H; Aleksandrova K; Brennan P; Franceschi S; Roulland S; Casabonne D; de Sanjose S; Sánchez MJ; Huerta JM; Ardanaz E; Sala N; Overvad K; Tjønneland A; Halkjær J; Weiderpass E; Bueno-de-Mesquita HB; Vermeulen R; Peeters PH; Vineis P; Kelly RS; Khaw KT; Travis RC; Key TJ; Riboli E; Nieters A
Cancer Epidemiol Biomarkers Prev; 2015 Mar; 24(3):538-45. PubMed ID: 25542829
[TBL] [Abstract][Full Text] [Related]
18. Proliferative response of B chronic lymphocytic leukemia lymphocytes stimulated with IL2 and soluble CD23.
Brizard A; Morel F; Lecron JC; Dreyfus B; Brizard F; Barra A; Preud'homme JL
Leuk Lymphoma; 1994 Jul; 14(3-4):311-8. PubMed ID: 7950920
[TBL] [Abstract][Full Text] [Related]
19. CD23 and chronic lymphocytic leukemia.
Sarfati M
Blood Cells; 1993; 19(3):591-6; discussion 597-9. PubMed ID: 8018941
[TBL] [Abstract][Full Text] [Related]
20. Serum levels of soluble CD23, but not soluble CD25, predict disease progression in early stage B-cell chronic lymphocytic leukemia.
Knauf WU; Langenmayer I; Ehlers B; Mohr B; Adorf D; Nerl CH; Hallek M; Zwingers TH; Emmerich B; Thiel E
Leuk Lymphoma; 1997 Nov; 27(5-6):523-32. PubMed ID: 9477135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
